Alexion Pharmaceuticals
Boston-based Alexion Pharmaceuticals develops medicine for rare diseases. Among its products are a treatment for a rare blood disease as well as the only approved complement inhibitor to treat a rare central nervous system disorder. In April, the company reported first quarter total revenue of $1.6 billion, a 13% increase from the same quarter last year. After almost 30 years as an independent company, Alexion was acquired by AstraZeneca in June, 2021. Nearly 90% of Alexion’s shares are held by institutions, including its two biggest shareholders, Vanguard Group and BlackRock.
Company Information
As of 6/2/21
Country
U.S.
Headquarters
Boston
Industry
Pharmaceuticals
CEO
Marc Dunoyer
Website
Company Type
Private
Ticker
-
Revenues ($M)
$6,069.9
Profits ($M)
$603.4
Market Value ($M)
$33,596.1
Employees
3,837
Acquired by AstraZeneca (U.K.), July 21, 2021. Market value as of March 31, 2021.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$6,069.9
21.6%
Profits ($M)
$603.4
-74.9%
Assets ($M)
$18,103
-
Total Stockholder Equity ($M)
$11,651.2
-
Profit Ratios
Profit as % of Revenues
9.9%
Profits as % of Assets
3.3%
Profits as % of Stockholder Equity
5.2%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
272
EPS % Change (from 2019)
-74.6%
EPS % Change (5 year annual rate)
32.3%
EPS % Change (10 year annual rate)
18%
Total Return
Total Return to Investors (2020)
44.5%
Total Return to Investors (5 year, annualized)
-3.9%
Total Return to Investors (10 year, annualized)
14.5%
Measure Up Diversity & Inclusion Metrics
Measure Up Rank
329
Provides Day Care Services
yes
Facilitates Employee Resource Groups
-
Has a Policy on Board Diversity
yes
Has a Policy on Diversity and Opportunity
yes
Has Targets Toward Diversity and Opportunity
-
% of Employees With Disabilities
-
% of New Employees Who Are Women
-
% of Employees Who Are Women
-
% of Managers Who Are Women
-
Gender Pay Gap %
-
% of Board Members Who Are Minorities
-
% of Employees Who Are Minorities
-
% of Managers Who Are Minorities
-
Minorities Salary Gap %
-
Company Information
Location
-
Industry
-
Sector
-
Fortune 500 Rank
-
Fortune 500 Profile
-
Current Streak
-
Years on List
-
CEO
-
Website
-
Revenue, Net Income
Revenue Past Four Quarters
-
Net Income Past Four Quarters
-
Growth Rates
EPS 3 yr Annual Growth Rate
-
Rev 3 yr Annual Growth Rate
-
Total Return 3 yr Annual Rate
-
Beat S&P 3 yr Total Return?
-
Rank
EPS Growth Rank
-
Revenue Growth Rank
-
Total Return Rank
-
Lists ranking Alexion Pharmaceuticals